Paul Workman
Impact in
- Toxicology top 0.05%
- Cancer Research top 0.1%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Heat shock proteins research 113
- Cancer therapeutics and mechanisms 50
- Protein Degradation and Inhibitors 41
- ATP Synthase and ATPases Research 36
- Oncology 128
- Cancer-related Molecular Pathways 40
- Co-authors
- Paul A. Clarke (74 shared papers)Bissan Al‐Lazikani (25 shared papers)Udai Banerji (20 shared papers)Florence I. Raynaud (68 shared papers)Marissa Powers (14 shared papers)Michael I. Walton (35 shared papers)Swee Y. Sharp (40 shared papers)Ian Collins (21 shared papers)
- Journals
- British Journal of Cancer (49 papers)Cancer Research (36 papers)Biochemical Pharmacology (33 papers)Molecular Cancer Therapeutics (28 papers)Cancer Chemotherapy and Pharmacology (28 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Paul Workman
565 papers receiving 28.6k citations
Paul Workman's Hit Papers
Peers
Comparison fields: 5 of 168
- Toxicology 1.2k
- Cancer Research 4.2k
- Molecular Biology 18.7k
- Oncology 5.5k
- Computational Theory and Mathematics 2.6k
Countries citing papers authored by Paul Workman
This map shows the geographic impact of Paul Workman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Workman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Workman more than expected).
Fields of papers citing papers by Paul Workman
This network shows the impact of papers produced by Paul Workman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Workman. The network helps show where Paul Workman may publish in the future.
Co-authors
The 25 scholars most cited alongside Paul Workman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 566 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Guidelines for the welfare and use of animals in cancer research Hit paper breakdown → | 2010 | 1116 |
| 2 | Combinatorial drug therapy for cancer in the post-genomic era Hit paper breakdown → | 2012 | 815 |
| 3 | 2002 | 470 | |
| 4 | Discovery of small molecule cancer drugs: Successes, challenges and opportunities Hit paper breakdown → | 2012 | 467 |
| 5 | 2008 | 460 | |
| 6 | 2007 | 457 | |
| 7 | 2002 | 436 | |
| 8 | 2005 | 406 | |
| 9 | 2008 | 368 | |
| 10 | 2006 | 312 | |
| 11 | 1999 | 298 | |
| 12 | 2017 | 298 | |
| 13 | 1988 | 282 | |
| 14 | 2008 | 267 | |
| 15 | 2006 | 266 | |
| 16 | 1992 | 263 | |
| 17 | 2007 | 259 | |
| 18 | 1994 | 259 | |
| 19 | 2006 | 242 | |
| 20 | Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis. | 2001 | 237 |
About Paul Workman
Paul Workman is a scholar working on Molecular Biology, Oncology, Cancer Research, Computational Theory and Mathematics and Organic Chemistry, having authored 566 papers that have together received 29.7k indexed citations. Recurring topics across this work include Heat shock proteins research (113 papers), Computational Drug Discovery Methods (71 papers), Cancer, Hypoxia, and Metabolism (63 papers), Cancer therapeutics and mechanisms (50 papers), Pharmacogenetics and Drug Metabolism (45 papers), Protein Degradation and Inhibitors (41 papers), Cancer-related Molecular Pathways (40 papers) and ATP Synthase and ATPases Research (36 papers). The work is most often cited by research in Toxicology (1.2k citations), Cancer Research (4.2k citations), Molecular Biology (18.7k citations), Oncology (5.5k citations) and Computational Theory and Mathematics (2.6k citations). Paul Workman has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Paul A. Clarke, Bissan Al‐Lazikani, Udai Banerji, Florence I. Raynaud, Marissa Powers, Michael I. Walton, Swee Y. Sharp, Ian Collins, Alison Maloney and Michelle D. Garrett. Their work appears in journals such as British Journal of Cancer, Cancer Research, Biochemical Pharmacology, Molecular Cancer Therapeutics and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.